Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate (Q61794203)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 August 2007
edit
Language Label Description Also known as
English
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate
scientific article published on 14 August 2007

    Statements

    title
    Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylate (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    17698976
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17698976%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    3 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q61794203&oldid=2159533012"